Benzoheterocyclic derivatives
AssigneeOtsuka Pharmaceutical Co., Ltd.
InventorsHidenori Ogawa, Kazumi Kondo, Hiroshi Yamashita, Keizo Kan, Takayuki Matsuzaki, Tomoichi Shinohara, Yoshihisa Tanada, Muneaki Kurimura, Michiaki Tominaga, Yoichi Yabuuchi
Life of this patent
Estimating the term…
Abstract
A benzoheterocyclic derivative of the following formula [1]: and pharmaceutically acceptable salts thereof, which show excellent anti-vasopressin activity, vasopressin agonistic activity and oxytocin antagonistic activity, and are useful as a vasopressin antagonist, vasopressin agonist or oxytocin antagonist.
Claims38
A compound of formula 1:
- wherein G is a group of the formula:
- R1 is a hydrogen atom, a halogen atom, a lower alkyl group, a lower alkoxy group, a hydroxy group, a lower alkanoyloxy group, an amino group having optionally a lower alkyl substituent, a carboxy-substituted lower alkoxy group, a lower alkoxycarbonyl-substituted lower alkoxy group, or an aminocarbonyl-lower alkoxy group having optionally a lower alkyl substituent,
- R2 is a group of the formula:
- —NR4R5, in which R4 and R5 are the same or different and each a hydrogen atom, a lower alkyl group having optionally a hydroxy substituent, or a benzoyl group having optionally a halogen substituent on the phenyl ring;
- a hydrogen atom;
- a hydroxy group;
- a lower alkoxy group;
- a carboxy-substituted lower alkyl group;
- a cyano-substituted lower alkyl group;
- a tetrazolyl-substituted lower alkyl group;
- a lower alkanoyloxy-substituted lower alkyl group;
- a lower alkoxycarbonyl-substituted lower alkyl group;
- an amino-substituted lower alkanoyloxy group having optionally a lower alkyl substituent;
- a lower alkoxycarbonyl-substituted lower alkoxy group;
- a carboxy-substituted lower alkoxy group;
- a lower alkanoyl group;
- or
- a group of the formula:
- —(O)m—A—(CO)uNR6R7, in which m and u are each 0 or 1, but both m and u are not simultaneously 0, A is a lower alkylene group, R6 and R7 are the same or different and each a hydrogen atom, a lower alkoxy group, a lower alkyl group, an amino-substituted lower alkyl group having optionally a lower alkyl substituent, a carbamoyl-substituted lower alkyl group, an adamantyl-substituted lower alkyl group, a lower alkylsulfonyl group, or a phenyl group having optionally a halogen substituent, or R6 and R7 may bind together with the nitrogen atom to which they bond to form a 5- to 7-membered saturated heterocyclic group with or without being intervened with another nitrogen atom or an oxygen atom, said heterocyclic group being optionally substituted by a lower alkyl group or a phenyl-lower alkyl group,
- R3 is a hydrogen atom or a hydroxy-substituted lower alkyl group,
- or R2 and R3 may bind together to form an oxo group, a lower alkylidene group, a lower alkoxy-substituted lower alkylidene group, a lower alkoxycarbonyl-substituted lower alkylidene group, or a phenyl-substituted lower alkylidene group,
- R is
- a group of the formula:
- in which p is 1 or 2,
- R8 is a hydrogen atom, a lower alkyl group, a hydroxy group, an amino group having optionally a lower alkanoyl substituent, a nitro group, a halogen atom or a lower alkoxy group,
- R2 a lower alkanoyloxy group;
- a benzoyl group having optionally a lower alkyl substituent on the phenyl group;
- a cycloalkyl group;
- a phenyl group having optionally a substituent selected from lower alkyl group, a lower alkoxy group, a phenyl-lower alkoxy group, a hydroxy group, a lower alkanoyloxy group, a halogen-substituted-lower alkoxy group, a nitro group, an amino group having optionally a lower alkanoyl substituent, a phenyl group, and an amino-substituted lower alkoxy group having optionally a lower alkyl substituent;
- a phenoxy group;
- a phenyl-lower alkyl group having optionally a lower alkyl substituent on the phenyl ring;
- a phenyl-lower alkylamino-carbonyl group;
- an aminosulfonyloxy group having optionally a lower alkyl substituent;
- or a group of the formula:
- —(A)m—CHR12R13, in which A is the same as defined above, R12 is a hydrogen atom, a hydroxy group or a lower alkanoyloxy group, R13 is a phenyl group having optionally a lower alkyl substituent or a phenyl-lower alkyl group having optionally a lower alkyl substituent on the phenyl ring, and m is 0 or 1,
- X is a methylene group, or a group of the formula:
- ═CH—
- provided that when X is a methylene group, then R is a group of the formula:
- wherein R8 and p are as defined above and R9 is a lower alkanoyloxy group;
- a benzoyl group having optionally a lower alkyl substituent on the phenyl group;
- a phenoxy group;
- a phenyl-lower alkyl group having optionally a lower alkyl substituent on the phenyl ring;
- a phenyl-lower alkylaminocarbonyl group;
- an aminosulfonyloxy group having optionally a lower alkyl substituent;
- or a group of the formula:
- —(A)m—CHR12R13, in which A is the same as defined above, R12 is a hydrogen atom, a hydroxy group or a lower alkanoyloxy group, R13 is a phenyl group having optionally a lower alkyl substituent or a phenyl-lower alkyl group having optionally a lower alkyl substituent on the phenyl ring, and m is 0 or 1,
- when R1 is a hydrogen atom and R2 is a hydrogen atom, an amino group, a mono-lower alkylamino group or a di-lower alkylamino group, or R2 and R3 may bind together to form an oxo group, then R9 should not be a phenyl group having optionally a substituent selected from a hydroxy group, a lower alkyl group, a lower alkoxy group and a lower alkanoyloxy group on the phenyl ring, or
- or a pharmaceutically acceptable salt thereof.
The compound according to clam 4, wherein R3 is a hydroxy-substituted lower alkyl group, or a pharmaceutically acceptable salt thereof.
7-Chloro-5-[(4-ethyl-1-piperazinyl)carbonylmethyl]-1-(4-phenylbenzoyl)-2,3-dihydro-1H-benzazepine.
7-Chloro-5-[(4-ethyl-1-piperazinyl)carbonylmethyl]-1-(4-cyclohexylbenzoyl)-2,3-dihydro-1H-benzazepine.
5-Methoxycarbonylmethyl]-1-{[4-(N,N-dipropylamino)sulfonyloxy]benzyl]-2,3,4,5-tetrahydro-1H-benzazepine.
1-{4-[N-(2-Phenylethyl)aminocarbonyl]benzoyl}-2,3,4,5-tetra-hydro-1H-benzazepine.
7-Chloro-1-[(4-benzylbenzoyl)-2,3,4,5-tetrahydro-1H-benzazepine.
7-Chloro-5-[(4-methyl-1-piperazinyl)carbonylmethyl]-1-(4-benzylbenzoyl)-2,3,4,5-tetrahydro-1H-benzazepine.
7-Chloro-5-{N-[2-(N,N-diethylamino)ethyl]aminocarbonyl-methyl}-1-(4-phenylbenzoyl)-2,3-dihydro-1H-benzazepine.
7-Chloro-1-(3-methoxy-4-acetyloxybenzoyl)-2,3,4,5-tetrahydro-1H-benzazepine.
7-Chloro-5-[(4-methyl-1-piperazinyl)carbonylmethyl]-1-(4-phenoxybenzoyl)-2,3,4,5-tetrahydro-1H-benzazepine.
7-Chloro-5-[{N-[2-(N,N-diethylamino)ethyl]-N-methylamino}-carbonylmethyl]-1-{4-[1-(2-methylphenyl)-1-hydroxymethyl]benzoyl}-2,3,4,5-tetrahydro-1H-benzazepine.
7-Chloro-5-[{N-[2-(N,N-diethylamino)ethyl]-N-methylamino}-carbonylmethyl]-1-[4-(2-methylbenzoyl)benzoyl]-2,3,4,5-tetrahydro-1H-benzazepine.
5-Isopropylaminocarbonylmethyl-1-{[4-(N,N-dipropylamino))-sulfonyloxy]benzoyl}-2,3,4,5-tetrahydro-1H-benzazepine.
Dependencies are inferred from the claim text.